FOR INDUSTRY
PARTNERS

What could you do with patient-consented, regulatory-grade, real-world patient data? ROOT brings unprecedented value to all stakeholders in cancer care.

THE REALITY
Drug approvals are costly and time-consuming.

WHAT WE DELIVER
Access to regulatory-grade, real-world data can bring drugs to market more quickly and at a lower cost.

THE REALITY
Researchers need better access to specific cancer data, including pathology, staging, biomarkers, genomic sequencing, radiology, and treatment.

WHAT WE DELIVER
Research-quality data that meets rigorous scientific standards can help researchers conduct complex studies, publish in shorter time frames, and strengthen their opportunities for grant funding.

THE REALITY
Laboratories need evidence of clinical benefit of testing before they can receive payor coverage.

WHAT WE DELIVER
A database that matches diagnostic data, treatment details, and outcomes to provide the necessary evidence that a new test is clinically valuable, biologically sound, and scientifically validated.

THE REALITY
Artificial intelligence relies on quality data for algorithm development and application.

WHAT WE DELIVER
Standardized, high-quality, and real patient clinical data can help companies generate meaningful information and move medicine forward through predictive outcomes and new models for drug discovery.

THE REALITY
By aligning with Taproot Health, investors become catalysts for a new era in precision oncology, moving the world toward personalized care.

WHAT WE DELIVER
Taproot Health is building a new generation of real-world data. Our prospective, regulatory-grade data fill a missing research gap, bridging the current efforts of others and providing a more comprehensive picture of cancer patients. These data are needed by all stakeholders to advance cancer care.